Latest news

Thumbnail image for FDA expands scope of Novartis’ Promacta

FDA expands scope of Novartis’ Promacta

US regulators have expanded the scope of Novartis’ Promacta to include earlier use of the drug to treat adults and paediatric patients with severe aplastic anaemia (SAA) in combination with standard immunosuppressive therapy (IST).

19th November 2018

Thumbnail image for CHMP backs four medicines for approval

CHMP backs four medicines for approval

Four medicines have taken a giant leap closer to approval having won the backing of the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP).

19th November 2018

Thumbnail image for Final NICE green light for Pfizer’s Mylotarg

Final NICE green light for Pfizer’s Mylotarg

Cost regulators for the NHS in England and Wales have now published final guidelines recommending Mylotarg, alongside daunorubicin and cytarabine, as an option for untreated de novo CD33-positive acute myeloid leukaemia (AML).

15th November 2018

Previous  --   3 4 5 6 7 8 9 10 11 12   --  Next

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download